研究者在治疗致命的脑癌, 血浆瘤的多种形态方面取得了突破。 Researchers make breakthrough in treating deadly brain cancer, glioblastoma multiforme.

研究人员在治疗血浆瘤多型(GBM)方面取得了突破。 血浆瘤多型(GBM)是最具攻击性的脑癌,一般只有14个月的病人在诊断后存活下来。 Researchers have made a breakthrough in treating glioblastoma multiforme (GBM), the most aggressive brain cancer, which typically offers patients only 14 months of survival after diagnosis. 这项研究提出了一种新的方法, 可以以两种关键方式针对GBM, 潜在地改变这种具有抗药性癌症的治疗结果. The study suggests a new approach that could target GBM in two critical ways, potentially transforming treatment outcomes for this historically resistant cancer.